Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Other Accumulated Expenses (2023 - 2025)

Guardian Pharmacy Services' Other Accumulated Expenses history spans 3 years, with the latest figure at $22.3 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 9.12% year-over-year to $22.3 million; the TTM value through Dec 2025 reached $22.3 million, up 9.12%, while the annual FY2025 figure was $22.3 million, 9.12% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $22.3 million at Guardian Pharmacy Services, up from $17.6 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $26.5 million in Q1 2025 and bottomed at $14.5 million in Q2 2025.
  • The 3-year median for Other Accumulated Expenses is $17.6 million (2025), against an average of $19.0 million.
  • The largest annual shift saw Other Accumulated Expenses increased 25.79% in 2024 before it rose 9.12% in 2025.
  • A 3-year view of Other Accumulated Expenses shows it stood at $16.2 million in 2023, then rose by 25.79% to $20.4 million in 2024, then rose by 9.12% to $22.3 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Other Accumulated Expenses are $22.3 million (Q4 2025), $17.6 million (Q3 2025), and $14.5 million (Q2 2025).